ESPE Abstracts (2016) 86 P-P1-561

ESPE2016 Poster Presentations Perinatal Endocrinology P1 (24 abstracts)

A Case of Hyperinsulinemic Hypoglycemia, Associated with Insulin Autoimmune Syndrome (IAS) in 3.5 Year Old Girl

Elena Kuznetsova & Mariya Melikyan


Endocrinology Research Center, Moscow, Russia


Background: Insulin Autoimmune Syndrome (IAS) is a rare cause of hyperinsulinemic hypoglycaemia with only few descriptions in children in the literature. Drugs containing the sulfhydryl group, such as methimazol, are known to be a causative factor of this syndrome. Diazoxide and octreotide are usually ineffective in such patients.

Objective: We aim to describe a rare case of IAS in a child, with a good response to a short course of glucocorticoid therapy.

Results: A previously healthy 3.5 year old Caucasian girl presented with hypoglycemic seizures. It is known that she had two courses of Piritinol treatment before the onset of the disease- for 1 month (6 months before) and for 2 weeks (10 days before). On admission blood glucose monitoring showed recurrent episodes of fasting hypoglycemia (1.7–2.8 mmol/l) and postprandial hyperglycemia (11–16 mmol/l), fasting tolerance was no longer than 1.5–2 h. Fasting test revealed non-ketotic hyperinsulinemic hypoglycemia: blood glucose 2.9 mmol/l, insulin >1000 μUn/ml, C-peptide 16.8 ng/ml. OGTT showed hyperglycemia (14.7 mmol/l) at 90 minute, but normal glucose levels at 120 min. (6.9 mmol/l). Based on extremely high levels of serum insulin in the absence of sulfonylurea intake, IAS was suspected. High levels of AIAb (>100 U/ml) and typical HLA alleles (DRB1* 04; DQA1* 0301) confirmed the diagnosis. To suppress autoimmunity, the girl was started on Prednisone 1.4 mg/kg per day. Normoglycemia was achieved in 3 days, but insulin and antibody levels remained elevated. Dose of prednisone was gradually reduced; treatment was stopped in 6 weeks. Follow up 2 months later showed clinical remission with negative fasting test, normalization of insulin secretion, but still mildly elevated AIAb (24.4 U/ml).

Conclusion: To our knowledge this is a first description of IAS in children in Russian Federation. We suspect that the likely trigger factor of the disease in this case was treatment of Piritinol, which has a disulfide bond, although we have not found information about the same cases in the literature. A short course of glucocorticoid treatment was effective in our case and might be recommended as an immunosuppressive therapy to achieve the remission rapidly.

Volume 86

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sep 2016 - 12 Sep 2016

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.